# Ricard Cervera

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ricard-cervera/

## Facts

| Field | Value |
| --- | --- |
| Citations | 70,245 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 112 |
| i10-index | 519 |
| Last Known Institution | Hospital Clínic de Barcelona |
| OpenAlex ID | https://openalex.org/A5039223320 |
| ORCID iD | https://orcid.org/0000-0001-6085-492X |
| Works | 951 |

## Researcher papers

Showing 12 of 27.

- [2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology/)
- [Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients](https://scholariq.org/papers/antiphospholipid-syndrome-clinical-and-immunologic-manifestations-and-patterns/)
- [2019 update of the EULAR recommendations for the management of systemic lupus erythematosus](https://scholariq.org/papers/2019-update-of-the-eular-recommendations-for-the-management-of-systemic-lupus/)
- [A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus](https://scholariq.org/papers/a-phase-iii-randomized-placebo-controlled-study-of-belimumab-a-monoclonal/)
- [2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period](https://scholariq.org/papers/morbidity-and-mortality-in-systemic-lupus-erythematosus-during-a-10-year-period/)
- [EULAR recommendations for the management of antiphospholipid syndrome in adults](https://scholariq.org/papers/eular-recommendations-for-the-management-of-antiphospholipid-syndrome-in-adults/)
- [Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide](https://scholariq.org/papers/immunosuppressive-therapy-in-lupus-nephritis-the-euro-lupus-nephritis-trial-a/)
- [Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis](https://scholariq.org/papers/joint-european-league-against-rheumatism-and-european-renal-association-european/)
- [EULAR recommendations for the management of systemic lupus erythematosus: 2023 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-systemic-lupus-erythematosus-2023/)
- [Systemic Lupus Erythematosus](https://scholariq.org/papers/systemic-lupus-erythematosus-2/)
- [Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients](https://scholariq.org/papers/morbidity-and-mortality-in-the-antiphospholipid-syndrome-during-a-10-year-period/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Researcher university

- [Hospital Clínic de Barcelona](https://scholariq.org/institutions/hospital-clinic-de-barcelona/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.